-
EP1932520
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1932520
| EP1932520 - Nutritional supplement composition for treatment of ocular diseases [Right-click to bookmark this link] | Status | The application has been refused Status updated on 12.11.2008 Database last updated on 30.03.2026 | Most recent event Tooltip | 12.11.2008 | Refusal of application | published on 03.12.2008 [2008/49] | Applicant(s) | For all designated states Novartis AG Lichtstrasse 35 4056 Basel / CH | [N/P] |
| Former [2008/25] | For all designated states Novartis AG Lichtstrasse 35 4056 Basel / CH | Representative(s) | von Sprecher, Georg Novartis AG Corporate Intellectual Property 4002 Basel / CH | [N/P] |
| Former [2008/25] | von Sprecher, Georg Novartis AG Corporate Intellectual Property 4002 Basel / CH | Application number, filing date | 06126259.8 | 15.12.2006 | [2008/25] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP1932520 | Date: | 18.06.2008 | Language: | EN | [2008/25] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 31.05.2007 | Classification | IPC: | A61K31/07, A61K31/202, A61K31/30, A61K31/315, A61K31/355, A61K31/375, A61P27/02 | [2008/25] | CPC: |
B41J2/17546 (EP,US);
A61K31/375 (EP,KR,US);
A61K31/07 (EP,US);
A61K31/202 (EP,US);
A61K31/30 (EP,US);
A61K31/315 (EP,US);
A61K31/355 (EP,KR,US);
A61K33/34 (KR);
A61P27/02 (EP);
B41J2/17553 (EP,US);
G03G15/0855 (EP,US);
G03G15/0865 (EP,US);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2008/25] | Extension states | AL | Not yet paid | BA | Not yet paid | HR | Not yet paid | MK | Not yet paid | RS | Not yet paid | Title | German: | Nahrungsergänzungsmittel zur Behandlung von Augenerkrankungen | [2008/25] | English: | Nutritional supplement composition for treatment of ocular diseases | [2008/25] | French: | Composition de suppléments nutritionels pour traiter des maladies oculaires | [2008/25] | Examination procedure | 14.07.2008 | Despatch of communication that the application is refused, reason: Examination on filing A.90(5) [2008/49] | 24.07.2008 | Application refused, date of legal effect [2008/49] |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X] DE202005012984 (W & B PHARMAMARKEN GMBH et al.) [X] 1-15 * paragraphs [0001] - [0034]; claim 7 * | [X] US2005249821 (PAUL EDWARD L JR et al.) [X] 1-15 * paragraphs [0001] , [0013] - [0022]; claim -; table 1 * | [XY] US2005244510 (SMITH KYL L et al.) [X] 1-8,13-15 * paragraphs [0030] - [0044]; claim - *[Y] 9-12 | [Y] PHELPS BROWN N A ET AL: "NUTRITION SUPPLEMENTS AND THE EYE", EYE, ROYAL COLLEGE OF OPHTALMOLOGISTS, LONDON, GB, vol. 12, February 1998 (1998-02-01), pages 127 - 133, XP000991021 [Y] 1-15 * the whole document * | [Y] DONALDSON M J ET AL: "Treatment of nonexudative (dry) age-related macular degeneration", CURRENT OPINION IN OPHTHALMOLOGY 2006 UNITED STATES, vol. 17, no. 3, 2006, pages 267 - 274, XP009083755, ISSN: 1040-8738 [Y] 1-15 * page 269, column 1, paragraph 1 - column 2, paragraph 4 * DOI: http://dx.doi.org/10.1097/01.icu.0000193101.13551.e5 |